Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.55 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | GRM2 | Q14416 | 5/20 | 0.39 |
| ▸ | RAD52 | P43351 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19283428 | 1.00 | CYP1A2 (0.55) | CYP1A2EPHX1PPARGALDH1A1GRM2 | |
| SCHEMBL15654842 | 0.92 | CYP1A2 (0.60) | CYP1A2EPHX1PPARGALDH1A1GRM2 | |
| SCHEMBL15656524 | 0.90 | CYP1A2 (0.57) | CYP1A2EPHX1PPARGALDH1A1GRM2 | |
| SCHEMBL15657730 | 0.85 | CYP1A2 (0.50) | CYP1A2EPHX1PPARGGRM2 | |
| SCHEMBL30644213 | 0.83 | CYP1A2 (0.57) | CYP1A2EPHX1PPARGALDH1A1GRM2 | |
| SCHEMBL28215089 | 0.78 | CYP1A2 (0.64) | CYP1A2EPHX1PPARGALDH1A1GRM2 | |
| SCHEMBL5538728 | 0.78 | CYP1A2 (0.41) | CYP1A2EPHX1PPARG | |
| SCHEMBL29065673 | 0.77 | CYP1A2 (0.50) | CYP1A2EPHX1PPARGALDH1A1GRM2 | |
| SCHEMBL23375227 | 0.76 | CYP1A2 (0.42) | CYP1A2EPHX1PPARG | |
| SCHEMBL17265372 | 0.75 | CYP1A2 (0.54) | CYP1A2EPHX1PPARGALDH1A1GRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4452934-A1 | IONIZABLE DISULFIDE LIPIDS AND LIPID NANOPARTICLES DERIVED THEREFROM | Providence Therapeutics Holdings Inc. (CA) | 2024-10-30 | — | — | EP | disclosed |
| WO-2023115221-A1 | IONIZABLE DILSULFIDE LIPIDS AND LIPID NANOPARTICLES DERIVED THEREFROM | PROVIDENCE THERAPEUTICS HOLDINGS INC. (CA) | 2023-06-29 | — | — | WO | disclosed |